Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Diabetics: Liquid gel insert on prescription

Discussion in 'Diabetic Foot & Wound Management' started by Cameron, Mar 19, 2015.

  1. Cameron

    Cameron Well-Known Member

  2. Ben Lovett

    Ben Lovett Active Member

    Here's the study:

    Abstract
    Objectives

    Co-existing diabetes and peripheral vascular disease have increased susceptibility to plantar ulceration. Therapeutic insoles reduce plantar pressure, but the effect on transcutaneous tissue oxygenation (TcpO2) is unknown. This study examines the effect of gel-filled Liqua Care® therapeutic insoles on plantar pressure, and foot TcpO2, in at-risk individuals with diabetes and peripheral vascular insufficiency.

    Research design and methods

    Ankle brachial pressure index (ABPI) in both lower limbs was measured in patients attending the diabetes centre for complication screening; 21 individuals with ABPI <0.9 and no active ulceration were invited to participate in the study. TcpO 2 was measured at the apex of the great toes both before, and after a 2-week period of Liqua Care® insole use. Recordings of in-shoe pressure measurements without, and with the therapeutic insole were made to ascertain any regional redistribution of plantar pressures (forefoot, midfoot and hindfoot).

    Results

    A mean reduction in peak forefoot pressure of 54.7 kPa (95% confidence interval (CI) 31.7—77.8 kPa, p<0.01) was observed. Mean great toe TcpO2 increased by 2.92 mmHg (95% CI 0.87—4.97 mmHg, p<0.01).

    Conclusions

    These insoles may prevent new and recurrent pedal ulceration in at-risk patients with diabetes and peripheral vascular disease.

    full paper is available at - http://dvd.sagepub.com/content/11/2/80.full.pdf

    It's a shame they didn't separate ther pressure analysis into plantar digital and plantar metatarsal areas as these respond very differently to orthoses.

    Ben
     
Loading...

Share This Page